Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

NCT04463264 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

Laboratorios Roemmers S.A.I.C.F.